Cite
Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.
MLA
He, Changjun, et al. “Downregulating Hypoxia-Inducible Factor-2α Improves the Efficacy of Doxorubicin in the Treatment of Hepatocellular Carcinoma.” Cancer Science, vol. 103, no. 3, Mar. 2012, pp. 528–34. EBSCOhost, https://doi.org/10.1111/j.1349-7006.2011.02177.x.
APA
He, C., Sun, X.-P., Qiao, H., Jiang, X., Wang, D., Jin, X., Dong, X., Wang, J., Jiang, H., & Sun, X. (2012). Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Science, 103(3), 528–534. https://doi.org/10.1111/j.1349-7006.2011.02177.x
Chicago
He, Changjun, Xue-Pu Sun, Haiquan Qiao, Xian Jiang, Dongdong Wang, Xiangguo Jin, Xuesong Dong, Jizhou Wang, Hongchi Jiang, and Xueying Sun. 2012. “Downregulating Hypoxia-Inducible Factor-2α Improves the Efficacy of Doxorubicin in the Treatment of Hepatocellular Carcinoma.” Cancer Science 103 (3): 528–34. doi:10.1111/j.1349-7006.2011.02177.x.